PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 26,792 Value ($000) $2,340 Avg Close $81.85 Range $62.24 - $96.54

Q1 2025

Shares 19,847 Value ($000) $960 Avg Close $41.90 Range $33.70 - $60.60

Q2 2024

Shares 10,895 Value ($000) $378 Avg Close $29.29 Range $24.22 - $35.96

Q1 2024

Shares 9,182 Value ($000) $266 Avg Close $27.21 Range $21.43 - $33.34

Q2 2023

Shares 9,210 Value ($000) $254 Avg Close $25.03 Range $17.64 - $30.10

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	26,792	$2,340	$81.85	$62.24 - $96.54
Q1 2025	19,847	$960	$41.90	$33.70 - $60.60
Q2 2024	10,895	$378	$29.29	$24.22 - $35.96
Q1 2024	9,182	$266	$27.21	$21.43 - $33.34
Q2 2023	9,210	$254	$25.03	$17.64 - $30.10